Health Spending Now Exceeds Prepandemic Levels As Utilization Of Care Remains Uneven

Both health care spending and utilization have changed significantly since before the pandemic, the new Peterson-KFF Health System Tracker found.

“As of the first quarter of 2024, most spending on health services exceeds pre-pandemic levels, and health costs are growing at a faster rate than in recent years,” it said. “However, utilization of care has been uneven by setting and market. Some measures of hospital utilization remain lower than pre-pandemic levels, which could reflect a continuing transition of care to outpatient centers.”

Several key findings about cost and utilization emerged from the report.

Annual growth in health services spending now higher than before the pandemic. Since early 2022, year-over-year growth in health services spending rebounded as the system recovered from the initial waves of the COVID-19 pandemic. Some of this growth in spending reflects rising prices, as inflation and workforce shortages have put upward pressure on hospital costs.

Spending on hospitals is now growing faster than before the pandemic. After some volatility from 2020 through 2022, growth in hospital services spending has been consistently high, with double-digit growth since early 2023.

Hospital discharges have remained below pre-pandemic levels. By the first quarter of 2024, the number of hospital discharges had rebounded to 9.3 million, but that was still about 0.5 million short of the typical number of discharges in 2018 and 2019.

On a per capita basis, inpatient admissions had been trending downward over time, even before the pandemic. There has been a move from inpatient settings to outpatient care centers for some types of care, such as imaging and diagnostic services, and less-complex surgical procedures.

The percentage of adults with a visit to an emergency department has rebounded to pre-pandemic levels. The share of adults reporting an emergency department visit in the previous 12 months dropped to 17% in the fourth quarter of 2020. However, this number has rebounded in the past year, with 20.7% of adults reporting a visit in the first quarter of 2024.

Hospital outpatient visits generally are trending upward. From 2019 to 2020, there was a nearly 10% decrease as care was delayed, foregone or cancelled because of COVID-19. The rate of outpatient visits since has recovered and in 2022 was marginally above pre-pandemic levels.

The share of adults with a doctor visit in the past year is similar to pre-pandemic levels. From 2000 to 2022, there was a 30% increase in the rate of outpatient visits.

The share of adults with a doctor visit in the past year is similar to pre-pandemic levels. The percentage of adults with a doctor visit in the last year has recovered since 2020 and is similar to pre-pandemic levels.

Ambulatory encounters are increasing in the fully insured group and Medicare Advantage markets. The average number of ambulatory encounters per enrollee in Medicare Advantage has grown in recent years, while the number of ambulatory care encounters per Medicaid enrollee has fallen since pre-pandemic.

 

Source Link

Recommended Articles

P4ESC Warns Congress Not to Tax Health Benefits

“We oppose taxing health benefits,” said Neil Trautwein, P4ESC’s Executive Director. “Policymakers will find how widely unpopular the idea will be with Americans with this type of coverage if they take this unwise step,” added Trautwein.

Read More

At Social Security, These Are the Days of the Living Dead

In multiple instances over the past few weeks, Social Security Offices have seen people come in for whom “there is no information on the record, just that they are dead.” So employees have to “resurrect” them — affirm that they’re living, so they can receive their benefits.

Read More

Out-Of-Pocket Drug Spending Hit $98B In 2024: Report

Americans spent $98 billion out of pocket on prescription drugs in 2024, marking a cumulative 25% increase over five years, according to an annual report from analytics firm IQVIA. Why it matters: Lowering prescription drug costs remains a priority for both Democrats and Republicans. The Biden administration led Congress in passing a landmark legislative package to negotiate select drug ...

Read More

Trump Signs Executive Order To Encourage U.S. Drug Manufacturing

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing. The order directs the U.S. Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square